Xlife Sciences AG Income Statement

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	0.28	0.83	0.99	1.03	0.81
Revenue Growth (YoY)	-67.02%	-15.53%	-3.85%	27.53%	103.14%
Cost of Revenue	0.27	0.29	0.54	0.84	0.45
Gross Profit	0.01	0.55	0.45	0.19	0.36
Selling, General & Admin	3.61	4.1	4.75	5.2	5.53
Other Operating Expenses	-0.4	-0.26	-0.02	-0.05	-0
Operating Expenses	31.57	19.9	20.75	21.17	5.59
Operating Income	-31.56	-19.35	-20.31	-20.98	-5.23
Interest Expense	-0.62	-0.47	-0.39	-0.69	-0.5
Interest & Investment Income	-	0.38	0.03	0.21	0.1
Earnings From Equity Investments	-0.26	-13.23	-7.8	-9.02	-0.97
Currency Exchange Gain (Loss)	-	0.06	-0.74	-0.24	-0.13
Other Non Operating Income (Expenses)	0.29	0	-	-0	0
EBT Excluding Unusual Items	-32.14	-32.62	-29.21	-30.72	-6.73
Gain (Loss) on Sale of Investments	1.92	56.54	15.88	34.76	-18.12
Asset Writedown	-	0	-0	-0	-
Other Unusual Items	-1.63	0.04	17.87	-	78.05
Pretax Income	-31.86	23.97	4.53	4.04	53.19
Income Tax Expense	-4.74	-4.74	-4.74	-4.74	-0.08
Earnings From Continuing Operations	-27.12	28.71	9.27	8.78	53.28
Minority Interest in Earnings	5.57	5.57	5.61	5.53	0.14
Net Income	-21.55	34.28	14.88	14.31	53.42
Net Income to Common	-21.55	34.28	14.88	14.31	53.42
Net Income Growth	-	130.37%	3.96%	-73.21%	148.91%
Shares Outstanding (Basic)	6	6	5	5	5
Shares Outstanding (Diluted)	6	7	7	7	6
Shares Change (YoY)	-21.94%	1.34%	-0.17%	17.26%	4.77%
EPS (Basic)	-3.76	6.00	2.73	2.72	11.30
EPS (Diluted)	-3.76	4.54	2.08	2.00	8.66
EPS Growth	-	118.26%	4.15%	-76.95%	136.46%
Free Cash Flow	-1.28	-0.43	0.16	-4.62	-4.48
Free Cash Flow Per Share	-0.22	-0.06	0.02	-0.64	-0.72
Gross Margin	3.38%	65.82%	45.43%	18.06%	44.55%
Operating Margin	-11462.04%	-2317.30%	-2054.30%	-2041.02%	-649.21%
Profit Margin	-7826.51%	4105.62%	1505.34%	1392.26%	6627.06%
Free Cash Flow Margin	-463.19%	-51.94%	15.97%	-449.70%	-555.75%
EBITDA	-3.2	-3.39	-4.38	-5.07	-5.2
D&A For EBITDA	28.36	15.96	15.92	15.91	0.03
EBIT	-31.56	-19.35	-20.31	-20.98	-5.23

Source: S&P Global Market Intelligence. Standard template. Financial Sources.